SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 42.83 |
| Enterprise Value ($M) | -6.34 |
| Book Value ($M) | 26.42 |
| Book Value / Share | 1.26 |
| Price / Book | 1.62 |
| NCAV ($M) | -21.76 |
| NCAV / Share | -1.04 |
| Price / NCAV | -1.97 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.26 |
| Return on Assets (ROA) | -0.56 |
| Return on Equity (ROE) | -0.83 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.57 |
| Current Ratio | 3.57 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 89.47 |
| Assets | 137.65 |
| Liabilities | 111.23 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.00 |
| Operating Income | -139.16 |
| Net Income | -130.93 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -92.46 |
| Cash from Investing | -41.89 |
| Cash from Financing | 120.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 0.00 | -100.00 | |
| 13G | Rush Ryan Bradford | 5.10 | ||
| 13G/A | Vivo Opportunity Fund Holdings, L.P. | 1.10 | -98.54 | |
| 13G/A | Commodore Capital Lp | 0.00 | -100.00 | |
| 13G/A | Logos Global Management LP | 2.00 | -97.22 | |
| 13G/A | Fmr Llc | 1.13 | -96.17 | |
| 13G | BlackRock, Inc. | 7.20 | 0.00 | |
| 13G/A | Morgan Stanley | 0.40 | -98.47 | |
| 13G | Franklin Resources Inc | 8.50 | ||
| 13G | Stern Augustus | 5.37 | ||
| 13G | Principia Wealth Advisory, LLC | 5.07 | ||
| 13G/A | BML Investment Partners, L.P. | 10.60 | 93.37 | |
| 13D/A | Versant Ventures IV, LLC | 2.40 | -90.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 129,843 | 733,561 | 17.70 | |
| 171,782 | 794,236 | 21.63 | |
| 304,038 | 1,033,156 | 29.43 | |
| 72,279 | 600,053 | 12.05 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACXP – Acurx Pharmaceuticals, Inc. | ADIL – Adial Pharmaceuticals, Inc. |
| ADTX – Aditxt, Inc. | AGEN – Agenus Inc. |
| AIMD – Ainos, Inc. |
Financial data and stock pages provided by
Fintel.io